Ade, Yonata and Syazili, Mustofa (2022) KARAKTERISTIK, MEKANISME AKSI, DAN EFIKASI VAKSIN DALAM VAKSINASI GLOBAL PANDEMI COVID-19. Jurnal Ilmu Kedokteran Dan Kesehatan, 9 (2). pp. 786-795. ISSN ISSN 2355-7583 (Cetak) dan ISSN 2549-4864 (Online)
|
Text
KARAKTERISTIK, MEKANISME AKSI, DAN EFIKASI VAKSIN DALAM VAKSINASI GLOBAL PANDEMI COVID-19.pdf Download (181kB) | Preview |
Abstract
This review considers vaccines developed against SARS-CoV-2 in the period of the Covid-19 pandemic. In this search, we will discuss the mechanism of action of each vaccine as well as its efficacy and safety. Four vaccines are currently in common use in various countries: Pfizer-BioNTech (USA), Moderna (USA), Astra-Zeneca (UK), and Janssen Johnson & Johnson (USA). In addition, there are two vaccines that are only used by a few countries: Novavax (USA) and SInovax (China) for which data are not widely studied. Pfizer and Moderna's efficacy for preventing disease or severe illness was 95–87.5% and 94.5–100%, respectively. The efficacy of Astra-Zeneca and Janssen Johnson & Johnson are around 70% and 57-72%, respectively. Meanwhile, Sinovax and Novavax vaccines have efficacy of about 65-90% and 60-89.7%, respectively, for prevention against Covid-19. The vaccination strategy is based on accelerating the administration of vaccines, so that as many subjects as possible can be vaccinated quickly to achieve herd immunity.
| Item Type: | Article |
|---|---|
| Subjects: | R Medicine > R Medicine (General) |
| Divisions: | Fakultas Kedokteran (FK) > Prodi Pendidikan Dokter |
| Depositing User: | Dr.Si. dr. Syazili Mustofa |
| Date Deposited: | 04 Nov 2022 08:29 |
| Last Modified: | 04 Nov 2022 08:29 |
| URI: | http://repository.lppm.unila.ac.id/id/eprint/46254 |
Actions (login required)
 |
View Item |